ARCHIVES

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

This article is from The Cancer Letter archive.

Vol. 21 No. 23 | June 9, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Proposes Guidelines For Testing New Anticancer Drugs

November 14, 1975

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

Politicians Applaud CPRIT’s New Direction; UT Gives Waiver To MD Anderson’s DePinho

October 26, 2012

NCI Adds $700,000 to CCOP Budget, Makes Four New Awards

June 9, 1989

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984

I-ELCAP: NEJM And Other Journals Seek Information On The Study’s Confidential Review From Henschke And Her Employers

May 6, 2011